Literature DB >> 17984435

Transluminal replacement of displaced peritoneal catheter using a special "alpha-replacer" guidewire: effectiveness and limitations.

Hiroyuki Terawaki1, Masaaki Nakayama, Hirofumi Nakano, Toshio Hasegawa, Makoto Ogura, Tatsuo Hosoya, Tomokazu Karino.   

Abstract

BACKGROUND: Transluminal replacement of a displaced peritoneal catheter (TRC) using a metal guidewire is a noninvasive treatment of catheter displacement with acute malfunction. The "alpha-replacer" is a special guidewire developed specifically for TRC. This wire is usually flexible but becomes harder if coiled in the hand. Application of this unique guidewire might improve the effectiveness of TRC.
METHODS: TRC using an alpha-replacer was performed in 10 cases for urgent correction of peritoneal catheter displacement. All patients had received a double cuffed, straight-end swan-neck catheter.
RESULTS: The primary success rate of TRC using the alpha-replacer was 90% (9 of 10 cases). No patients developed complications such as injury of the peritoneum or abdominal organs. Relapse of catheter displacement was observed in 2 cases (20%) within 1 week, requiring surgical intervention to prevent relapse.
CONCLUSION: TRC using the alpha-replacer as described herein offers effective and safe treatment of peritoneal catheter displacement.

Entities:  

Mesh:

Year:  2007        PMID: 17984435

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  2 in total

1.  Unroofing surgery with en bloc resection of the skin and tissues around the peripheral cuff.

Authors:  Hiroyuki Terawaki; Hirofumi Nakano; Makoto Ogura; Moritoshi Kadomura; Tatsuo Hosoya; Masaaki Nakayama
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

2.  Efficacy and safety of fluoroscopic manipulation using the alpha-replacer for peritoneal catheter malposition.

Authors:  Yosuke Saka; Yasuhiko Ito; Yoshiyasu Iida; Shoichi Maruyama; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-07-17       Impact factor: 2.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.